参考文献/References:
[1] Calne DB,Reid JL,Vakil SD,et al.Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa[J].Br Med J,1971,3(5777):729–732.
[2] Santini E,Heiman M,Greengard P,et al.Inhibition of mTOR signaling in Parkinson’s disease prevents L-DOPA-induced dyskinesia[J].Sci Signal,2009,2(80):ra36.
[3] Subramaniam S,Napolitano F,Mealer RG,et al.Rhes,a striatal-enriched small G protein,mediates mTOR signaling and L-DOPA-induced dyskinesia[J].Nat Neurosci,2011,15(2):191-193.
[4] Decressac M,Bj rklund A.mTOR Inhibition Alleviates L-DOPA-Induced Dyskinesia in Parkinsonian Rats[J].J Parkinsons Dis,2013,3(1):13-17.
[5] Neves G,Cooke SF,Bliss TV.Synaptic plasticity, memory and the hippocampus: a neural network approach to causality[J].Nat Rev Neurosci,2008,9(1):65 75.
[6] Picconi B,Centonze D,H kansson K,et al.Loss of bidirectional striatal synaptic plasticity in L-DOPA induced dyskinesia[J].Nat Neurosci,2003,6(5):501-506.
[7] Jenner P.Molecular mechanisms of L-DOPA-induced dyskinesia[J].Nat Rev Neurosci,2008,9(9):665-677.
[8] Torres EM,Lane EL,Heuer A,et al.Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates[J].J Neurosci Methods,2011,200(1):29-35.
[9] Paxinos G,Watson C.The rat brain in stereotaxic coordinates: hard cover edition[M].Academic press,2006.
[10] Thomas J,Wang J,TakubaH,et al.A 6-hydroxydopamine-induced selective parkinsonian rat model:further biochemical and behavioral characterization[J].Exp Neurol,1994,126(2):159-167.
[11] Monville C,Torres EM,Dunnett SB.Validation of the l-dopa-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists[J].Brain Res Bull,2005,68(1):16-23.
[12] Zhang J,Saur T,Duke AN,et al.Motor Impairments,Striatal Degeneration,and Altered Dopamine-Glutamate Interplay in Mice Lacking PSD-95[J].J Neurogenet,2014,28(1-2):98-111.
[13] Kim E,Sheng M.PDZ domain proteins of synapses[J].Nat Rev Neurosci,2004,5(10):771-781.
[14] Scannevin RH,Huganir RL.Postsynaptic organisation and regulation of excitatory synapses[J].Nat Rev Neurosci,2000,1(2):133-141.
[15] El-Husseini AE,Schnell E,Chetkovich DM,et al.PSD-95 involvement in maturation of excitatory synapses[J].Science,2000,290(5495):1364-1368.
[16] Porras G,Berthet A,Dehay B,et al.PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking[J].J Clin Invest,2012,122(122(11)):3977-3989.
[17] Kim MJ,Futai K,Jo J,et al.Synaptic accumulation of PSD-95 and synaptic function regulated by phosphorylation of serine-295 of PSD-95[J].Neuron,2007,56(3):488-502.
[18] Ehrlich I,Malinow R.Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity[J].J Neurosci,2004,24(4):916-927.
[19] Stein V,House DR,Bredt DS,et al.Postsynaptic density-95 mimics and occludes hippocampal long-term potentiation and enhances long-term depression[J].J Neurosci,2003,23(13):5503-5506.
[20] Ba M, Kong M, Ma G. Postsynaptic density protein 95-regulated nr2B tyrosine phosphorylation and interactions of Fyn with nr2B in levodopa-induced dyskinesia rat models[J]. Drug Des Devel The, 2014,19(9):199-206.
[21] Calabresi P,Gubellini P,Centonze D,et al.Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity[J].J Neurosci,2000,20(22):8443-8451.
[22] Kerr JN,Wickens JR.Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro[J].J Neurophysiol,2001,85(1):117-124.
[23] Fiorentini C,Gardoni F,Spano PF,et al.Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors[J].J Biol Chem,2003,278(22):20196-20202.
[24] Pascoli V,Besnard A,Herv D,et al.Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation[J].Biol Psychiatry,2011,69(3):218-227.
[25] Chen BS,Roche KW.Regulation of NMDA receptors by phosphorylation[J].Neuropharmacology,2007,53(3):362-368.
[26] Gerfen CR,Surmeier DJ.Modulation of striatal projection systems by dopamine[J].Annu Rev Neurosci,2011,34:441-466.
[27] Bellone C,Gardoni F.Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction Diseases[J].Front Cell Neurosci,2015,9:25.
[28] Snyder GL,Fienberg AA,Huganir RL,et al.A dopamine/D1 receptor/protein kinase A/dopamine-and cAMP-regulated phosphoprotein(Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor[J].J Neurosci,1998,18(24):10297-10303.
[29] Barria A,Malinow R.NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII[J].Neuron,2005,48(2):289-301.
[30] Lee FJ,Xue S,Pei L,et al.Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor[J].Cell,2002,111(2):219-230.
[31] Lee DK,Bian S,Rahman MA,et al.Repeated cocaine administration increases N-methyl-d-aspartate NR1 subunit,extracellular signal-regulated kinase and cyclic AMP response element-binding protein phosphorylation and glutamate release in the rat dorsal striatum[J].Eur J Pharmacol,2008,590(1-3):157-162.
[32] Dudman JT,Eaton ME, Rajadhyaksha A,et al.Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897 NR1[J].J Neurochem,2003,87(4):922-934.
[33] Choe ES,Shin EH,Wang JQ.Inhibition of protein phosphatase 2B upregulates serine phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in striatal neurons in vivo [J].Neurosci Lett,2005,384(1-2):38-43.
[34] Dunah AW,Wang Y,Yasuda RP,et al.Alterations in Subunit Expression, Composition, and Phosphorylation of StriatalN-Methyl-d-Aspartate Glutamate Receptors in a Rat 6-Hydroxydopamine Model of Parkinson’s Disease[J].Mol Pharmacol,2000,57(2):342-352.
[35] Masu M,Nakajima Y,Moriyoshi K,et al.Molecular characterization of NMDA and metabotropic glutamate receptors[J].Ann N Y Acad Sci,1993,707(1):153-164.
[36] Krupp JJ,Vissel B,Thomas CG,et al.Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors[J].Neuropharmacology,2002,42(5):593-602.
[37] Grosshans DR,Clayton DA,Coultrap SJ,et al.LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1[J].Nat Neurosci,2001,5(1):27-33.
[38] Moon IS,Apperson ML,Kennedy MB.The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B[J].Proc Natl Acad Sci USA,1994,91(9):3954-3958.
[39] Nakazawa T,Komai S,Tezuka T,et al.Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2(NR2B)subunit of the N-methyl-D-aspartate receptor[J].J Biol Chem,2001,276(l):693一699.
[40] Gardoni F,Sgobio C,Pendolino V,et al.Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias[J].Neurobiol Aging,2012,33(9):2138-2144.
[41] Gardoni F,Di Luca M.Targeting glutamatergic synapses in Parkinson’s disease[J].Curr Opin Pharmacol,2015,20:24-28.
[42] Kong M,Ba M,Liu C,et al.NR2B antagonist CP-101,606 inhibits NR2B phosphorylation at tyrosine-1472 and its interactions with Fyn in levodopa-induced dyskinesia rat model[J].Behav Brain Res, 2015,286:46-53.
[43] Xu Y,Liu C,Chen S,et al.Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson’s disease[J].Cell Signal,2014,26(8):1680-1689.
[44] Decressac M,Bj rklund A.mTOR inhibition alleviates L-DOPA-induced dyskinesia in parkinsonian rats[J].J Parkinsons Dis,2013,3(1):13-17.
[45] Cenci MA.Presynaptic mechanisms of L-DOPA-induced dyskinesia: the findings, the debate, and the therapeutic implications[J].Front Neurol,2014,5:242.
相似文献/References:
[1]黄立宏 李刚 冯小芳等. 15d-PGJ2对糖尿病大鼠脑缺血再灌注损伤小胶质细胞活化及神经细胞凋亡的影响[J].卒中与神经疾病杂志,2016,23(03):149.[doi:10.3969/j.issn.1007-0478.2016.03.001]
Huang Lihong,Li Gang,Feng Xiaofang,et al. Effect of 15d-PGJ2 on the activation of microglias and the apotosis of neurons after the injury of acute cerebral ischemia reperfusion in diabetic rats[J].Stroke and Nervous Diseases,2016,23(03):149.[doi:10.3969/j.issn.1007-0478.2016.03.001]
[2]黄锦丰 凌国源 玉石等. L-选择素在缺血性脑卒中患者外周血中的表达及其意义[J].卒中与神经疾病杂志,2016,23(03):154.[doi:10.3969/j.issn.1007-0478.2016.03.002]
Huang Jinfeng,Ling Guoyuan,Yu Shi,et al. L-selectin in peripheral blood of patients with ischemic cerebral stroke and its significance[J].Stroke and Nervous Diseases,2016,23(03):154.[doi:10.3969/j.issn.1007-0478.2016.03.002]
[3]袁波 谭李红 谭莉等. 介入栓塞与陀螺旋转式60钴放射治疗系统联合治疗颅内巨大动静脉畸形15例疗效观察[J].卒中与神经疾病杂志,2016,23(03):157.[doi:10.3969/j.issn.1007-0478.2016.03.003]
Yuan Bo,Tan Lihong,Tan Li,et al. Clinical analysis of 15 cases combined treatment of endovascular embolization and gyro 60 cobalt radiation system in giant cerebral arteriovenous malformations[J].Stroke and Nervous Diseases,2016,23(03):157.[doi:10.3969/j.issn.1007-0478.2016.03.003]
[4]王慧玲 黄朝云. 脑卒中后抑郁合并认知损害的磁共振扩散张量成像研究[J].卒中与神经疾病杂志,2016,23(03):160.[doi:10.3969/j.issn.1007-0478.2016.03.004]
Huiling,Huang Chaoyun.. A diffusion tensor imaging study in patients with post-stroke depression combined with cognitive impairmentWang[J].Stroke and Nervous Diseases,2016,23(03):160.[doi:10.3969/j.issn.1007-0478.2016.03.004]
[5]吕敏 吕琳 温慧军等. ABCD2评分预测头昏患者发生缺血性脑血管事件风险的研究[J].卒中与神经疾病杂志,2016,23(03):164.[doi:10.3969/j.issn.1007-0478.2016.03.005]
Lv Min,Lv Lin,Wen Huijun,et al. Application of the ABCD2 score to identify ischemic cerebrovascular events of patients with dizziness[J].Stroke and Nervous Diseases,2016,23(03):164.[doi:10.3969/j.issn.1007-0478.2016.03.005]
[6]李岚. 肌电图定位定量电刺激治疗上肢周围神经损伤的临床分析[J].卒中与神经疾病杂志,2016,23(03):167.[doi:10.3969/j.issn.1007-0478.2016.03.006]
Li Lan.. The clinical analysis of EMG quantitative electrical stimulation in the treatment of peripheral nerve injury of upper limb[J].Stroke and Nervous Diseases,2016,23(03):167.[doi:10.3969/j.issn.1007-0478.2016.03.006]
[7]李瑾 陈黛琪. 无创机械通气在重症肌无力危象治疗中的疗效[J].卒中与神经疾病杂志,2016,23(03):170.[doi:10.3969/j.issn.1007-0478.2016.03.007]
Li Jin,Chen Daiqi.. Therapeutic effect of noninvasive mechanical ventilation in the treatment of myasthenia gravis crisis[J].Stroke and Nervous Diseases,2016,23(03):170.[doi:10.3969/j.issn.1007-0478.2016.03.007]
[8]强毅娜 高杰. 富亮氨酸胶质瘤失活1蛋白抗体阳性相关免疫脑炎1例临床分析并文献复习[J].卒中与神经疾病杂志,2016,23(03):174.[doi:10.3969/j.issn.1007-0478.2016.03.008]
Qiang Yina,Gao Jie.. Clinical analysis of 1 patient with leucine-rich glioma inactivated-1 protein antibody positive limbic encephalitis:A case report and review of literature[J].Stroke and Nervous Diseases,2016,23(03):174.[doi:10.3969/j.issn.1007-0478.2016.03.008]
[9]宋楠 王红梅. 针吸型肌肉活检联合免疫荧光在假肥大型肌营养不良诊断中的应用[J].卒中与神经疾病杂志,2016,23(03):177.[doi:10.3969/j.issn.1007-0478.2016.03.009]
Song Nan,Wang Hongmei.. The application of needle muscle biopsy combined with immunofluorescence in diagnosing of pseudohypertrophic muscular dystrophy[J].Stroke and Nervous Diseases,2016,23(03):177.[doi:10.3969/j.issn.1007-0478.2016.03.009]
[10]杨小华 李格 管萍. 脑出血迟发型血肿扩大的机制探讨和治疗对策[J].卒中与神经疾病杂志,2016,23(03):180.[doi:10.3969/j.issn.1007-0478.2016.03.010]
[J].Stroke and Nervous Diseases,2016,23(03):180.[doi:10.3969/j.issn.1007-0478.2016.03.010]